In vivo role of complement-interacting domains of herpes simplex virus type 1 gC

Journal of Experimental Medicine

Volumn 190, Issue 11, 1999, Pages 1637-1646

  Lubinski, John ^a   Wang, Liyang ^a   Mastellos, Dimitri ^a   Sahu, Arvind ^a   Lambris, John D ^a   Friedman, Harvey M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

C3; Disease; Immunology; Innate immunity; Pathogenesis

Indexed keywords

VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; HUMAN; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; VIRUS MUTANT; VIRUS VIRULENCE;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; BINDING SITES; CERCOPITHECUS AETHIOPS; COMPLEMENT C3; COMPLEMENT C3B; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MICE; MICE, KNOCKOUT; RECOMBINANT PROTEINS; ROSETTE FORMATION; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EID: 0033430228     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.11.1637     Document Type: Article

References (41)

1. Stevens, J.G., and M.L. Cook. 1971. Latent herpes simplex virus in spinal ganglia of mice. Science. 173:843-845.
2. Kramer, M.F., S.-H. Chen, D.M. Knipe, and D.M. Coen. 1998. Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J. Virol. 72: 1177-1185.
3. Baucke, R.B., and P.G. Spear. 1979. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J. Virol. 32:779-789.
4. Frank, I., and H.M. Friedman. 1989. A novel function of the herpes simplex virus type 1 Fc receptor, participation in antibody bipolar bridging of antiviral lgG. J. Virol. 63:4479-4488.
5. Dubin, G., E. Socolof, I. Frank, and H.M. Friedman. 1991. The herpes simplex virus Fc receptor protects infected cells from antibody dependent cellular cytotoxicity. J. Virol. 65: 7046-7050.
6. Nagashunmugam, T., J. Lubinski, L. Wang, L.T. Goldstein, B.S. Weeks, P. Sundaresan, E.H. Kang, G. Dubin, and H.M. Friedman. 1998. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J. Virol. 5351-5359.
7. Johnson, D.C., M.J.C. Frame, M.W. Ligas, A.M. Cross, and N.D. Stow. 1988. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gl. J. Virol. 62:1347-1354.
8. Friedman, H.M., G.H. Cohen, R.J. Eisenberg, C.A. Seidel, and D.B. Cines. 1984. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature. 309:633-635.
9. Kostavasili, I., A. Sahu, H.M. Friedman, R.J. Eisenberg, G.H. Cohen, and J.D. Lambris. 1997. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J. Immmul. 158:1763-1771.
10. McNearney, T.A., C. Odell, V.M. Holers, P.G. Spear, and J.P. Atkinson. 1987. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J. Exp. Med. 166:1525-1535.
11. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P.M. van Endert, R. Tampe, P.A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature. 375:415-418.
12. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennick, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:411-415.
13. Fodor, W.L., S.A. Rollins, S. Bianco-Caron, R.P. Rother, E.R. Guilmette, W.V. Burton, J.-C. Albrecht, B. Fleckenstein, and S.P. Squinto. 1995. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J. Virol. 69:3889-3892.
14. Huemer, H.P., C. Larcher, S. van Drunen Littel-van den Hurk, and L.A. Babiuk. 1993. Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host. Arch. Virol. 130:353-364.
15. Isaacs, S.N., G.J. Kotwal, and B. Moss. 1992. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA. 89:628-632.
16. Mold, C., B.M. Bradt, G.R. Nemerow, and N.R. Cooper. 1988. Epstein-Barr virus regulates activation and processing of the third component of complement. J. Exp. Med. 168: 949-969.
17. Rother, R.P., S.A. Rollins, W.L. Fodor, J.-C. Albrecht, E. Setter, B. Fleckenstein, and S.P. Squinto. 1994. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J. Virol. 68:730-737.
18. Ploegh, H.L. 1998. Viral strategies of immune evasion. Science. 280:248-253.
19. Tal-Singer, R., G. Seidel-Dugan, L. Fries, H.P. Huemer, R.J. Eisenberg, G.H. Cohen, and H.M. Friedman. 1991. Herpes simplex virus glycoprotein C is a receptor for complement component iC3b. J. Infect. Dis. 164:750-753.
20. Fries, L.F., H.M. Friedman, G.H. Cohen, R.J. Eisenberg, C.H. Hammer, and M.M. Frank. 1986. Glycoprotein C of herpes simplex virus 1 is an inhibitor ot the complement cascade. J. Immunol. 137:1636-1641.
21. Hung, S.-L., C. Peng, I. Kostavasili, H.M. Friedman, J.D. Lambris, R.J. Eisenberg, and G.H. Cohen. 1994. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology. 203: 299-312.
22. Gerber, S.I., B.J. Belval, and B.C. Herold. 1995. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology. 214:29-39.
23. Friedman, H.M., L. Wang, N.O. Fishman, J.D. Lambris, R.J. Eisenberg, G.H. Cohen, and J. Lubinski. 1996. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J. Virol. 70:4253-4260.
24. Harris, S.L., I. Frank, A. Yee, G.H. Cohen, R.J. Eisenberg, and H.M. Friedman. 1990. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J. Infect. Dis. 162:331-337.
25. Hidaka, Y., Y. Sakai, T. Yasushi, and R. Mori. 1991. Glycoprotein gC of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis ot virus-infected cells. J. Gen. Virol. 72:915-921.
26. Lubinski, J.M., L. Wang, A.M. Soulika, R. Burger, R.A. Wetsel, H. Colten, G.H. Cohen, R.J. Eisenberg, J.D. Lambris, and H.M. Friedman. 1998. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J. Virol. 72:8257-8263.
27. Straus, S.E., A. Wald, R.G. Kost, R. McKenzie, A.G.M. Langenberg, P. Hohman, J. Lekstrom, E. Cox, M. Nakamura, R. Sekulovich, et al. 1997. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. J. Infect. Dis. 176:129-134.
28. Mertz, G.J., R. Ashley, R.L. Burke, J. Benedetti, C. Critchlow, C.C. Jones, and L. Corey. 1990. Double-blind placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J. Infect. Dis. 161:653-660.
29. Corey, L., A.G.M. Langenberg, R. Ashley, R.E. Sekulovich, A.E. Izu, J.M. Douglas, H.H. Handsfield, T. Warren, L. Marr, S. Tyring, et al. 1999. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection. Two randomized trials. JAMA (J. Am. Med. Assoc.). 282:331-340.
30. Prodeus, A.P., X. Zhou, M. Maurer, S.J. Galli, and M.C. Carroll. 1997. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature. 390:172-175.
31. Friedman, H.M., A. Yee, H. Diggelmann, J.C. Hastings, R. Tal-Singer, C.A. Seidel-Dugan, R.J. Eisenberg, and G.H. Cohen. 1989. Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells. Mol. Cell. Biol. 9:2303-2314.
32. Hung, S.-L., S. Srinivasan, H.M. Friedman, R.J. Eisenberg, and G.H. Cohen. 1992. Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J. Virol. 66:4013-4027.
33. Hammer, C.H., G.H. Wirtz, L. Renfer, H.D. Gresham, and B.F. Tack. 1981. Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256:3995-4006.
34. Pangburn, M.K. 1987. A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement. J. Immunol. Methods. 102:7-14.
35. Simmons, A., and A.A. Nash. 1984. Zosteriform spread of herpes simplex as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J. Virol. 52:816-821.
36. Fischer, M.B., A.P. Prodeus, A. Nicholson-Weller, M. Ma, J. Murrow, R.R. Reid, H.B. Warren, A.L. Lage, F.D. Moore, Jr., F.S. Rosen, et al. 1997. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J. Immunol. 159: 976-982.
37. Rux, A.H., W.T. Moore, J.D. Lambris, W.R. Abrams, C. Peng, H.M. Friedman, G.H. Cohen, and R.J. Eisenberg. 1996. Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus. J. Virol. 70:5455-5465.
38. Herold, B.C., D. WuDunn, N. Soltys, and P.G. Spear. 1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1090-1098.
39. WuDunn, D., and P.G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.
40. Tal-Singer, R., C. Peng, M.P. de Leon, W.R. Abrams, B.W. Banfield, F. Tufaro, G.H. Cohen, and R.J. Eisenberg. 1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J. Virol. 69:4471-4483.
41. Mascola, J.R. 1999. Herpes simplex virus vaccines - why don't antibodies protect? JAMA (J. Am. Med. Assoc.). 282: 379-380.